Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth
Share on
Filters

adidas Group: Impressive Q3 numbers, a more optimistic outlook

NEUTRAL, Fair Value EUR79 (-3%)

Published last November Thursday 5, 2015

Veolia Environnement: All eyes on next cost reduction programme

BUY, Fair Value EUR22 (+3%)

Published last November Thursday 5, 2015

DIA: Interview with the CEO

NEUTRAL, Fair Value EUR7,5 (+27%)

Published last November Wednesday 4, 2015
Bryan, Garnier & Co advises TRASYS’ shareholders on the sale of the company to the NRB Group

Bryan, Garnier & Co advises TRASYS’ shareholders on the sale of the company to the NRB Group

Published last November Tuesday 3, 2015

Worldline muscling up in Payments

Coverage initiated BUY, FV EUR27

Published last November Monday 2, 2015

Dialog reaffirms board's support for Atmel deal after ISS says holders should vote against

NEUTRAL, Fair Value EUR39 (+16%)

Published last November Monday 2, 2015

Fresenius Med. Care: CMS final rule does not impact guidance nor estimates

BUY Top Picks, Fair Value EUR90 (+11%)

Published last October Friday 30, 2015

ERYTech: Stronger penetration of Oncaspar in the US. Positive read-across for GRASPA

BUY, Fair Value EUR42 (+45%)

Published last October Friday 30, 2015

Capgemini: Q3 15 conference call feedback: business as usual during the integration of Igate

BUY, Fair Value EUR97 vs. EUR96 (+17%)

Published last October Friday 30, 2015

Voltalia: Strong Q3-15 sales development

BUY, Fair Value EUR13 (+27%)

Published last October Friday 30, 2015

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities